cancer drug

September 27, 2010 - 6:10 AM
Bob Svensson is hooked up to a blood infusion machine at the American Red Cross in Dedham, Mass., as he undergoes a $93,000 prostate cancer treatment. The Provenge therapy, approved in April, adds four months' survival, on average. (AP Photo/Elise Amendola)